Ian Goodwin

Director, Program Design at Fujifilm Diosynth Biotechnologies

Speaker

Ian Goodwin is Director of Program Design in the Viral Gene Therapy Global team at FUJIFILM Diosynth Biotechnologies in College Station, Texas. He has been with the company for five years, having also served as Associate Principal Scientist Group Leader in the Process Development group. Ian is currently responsible for providing strategic CMC guidance, technical design, and project scope development support to prospective clients engaged in CDMO selection for viral and non-viral cell & gene therapy products. Ian’s previous experience includes 10+ years working on process development and manufacturing strategies for stem cell, regenerative medicine, and gene therapy viral vectors - specifically adeno-associated virus (AAV) and lentivirus vectors (LV) in academic, start-up, and CDMO environments. Ian holds a Master’s Degree in Microbiology and Immunology from Drexel University College of Medicine and a B.Sc in Microbiology from The University of Pittsburgh.